{
    "clinical_study": {
        "@rank": "31881", 
        "acronym": "AASAP", 
        "arm_group": [
            {
                "arm_group_label": "Herbal application on acupoint group", 
                "arm_group_type": "Experimental", 
                "description": "Containing the herbal medicine application on the specific acupoints plus foundation treatment"
            }, 
            {
                "arm_group_label": "Placebo application on acupoint", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Not containing herbal medicine application on the specific acupoints plus foundation treatment"
            }, 
            {
                "arm_group_label": "Herbal application on non-acupoint group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Containing the herbal medicine application on the non-acupoints plus foundation treatment"
            }, 
            {
                "arm_group_label": "Placebo application on non-acupoint", 
                "arm_group_type": "Sham Comparator", 
                "description": "Not containing herbal medicine application on the non-acupoints plus foundation treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "Hypothesis: acupoint application  is effective for managing chronic stable angina pectoris.\n      Aim: to evaluate the efficacy and safety of acupoint application  on the specific acupoints\n      for chronic stable angina pectoris. Design: A Randomized, Controlled,Double Blind trial. 200\n      participants will be included. Four arms: herbal medicine application on acupoint group ,\n      placebo application on acupoint group , herbal medicine application on non-acupoint group\n      and placebo application on non-acupoint group."
        }, 
        "brief_title": "Acupoint Application in Patients With Stable Angina Pectoris (AASAP)", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Stable Angina Pectoris", 
        "condition_browse": {
            "mesh_term": "Angina Pectoris"
        }, 
        "detailed_description": {
            "textblock": "Acupoint application with herbal medicine is a kind of external treatment of traditional\n      Chinese medicine and has a long history in China, which is use herbal medicine made of\n      plaster and stick to specific acupoints, using the double effects of acupoints and herb to\n      treat disease. In China, acupoint application with herbal medicine has been used in clinical\n      treatment of angina pectoris, but there is no convincing evidence for the efficacy of\n      acupoint application for angina pectoris, due to low methodologic quality and small sample\n      size. The investigators designed the Randomized, Controlled, Double Blind clinical trial to\n      investigates the efficacy of acupoint application in treating angina pectoris, the purpose\n      of this study is to provide the convincing evidence for acupoint application treatment of\n      angina pectoris."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        1.Meet the diagnostic criteria of American College of Cardiology(ACC)/American Heart\n        Association (AHA) angina pectoris of coronary heart disease.\n\n        2.35 \u2264 age \u2264 85 years, both male and female.\n\n        3.The onset of angina pectoris\u22653 months, and the frequency of angina attack\u22652 a week.\n\n        4.Patients signed the informed consent\n\n        Exclusion Criteria:\n\n          1. age\u226435 or age\u226585.\n\n          2. Pregnant women or women in lactation or women of child bearing potential plan to\n             conceive in the recent six months.\n\n          3. history of diabetes.\n\n          4. Co-infection or bleeding, allergic.\n\n          5. Currently participating in other clinical trials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029118", 
            "org_study_id": "2011SZ0302.2"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Herbal application on acupoint group", 
                    "Herbal application on non-acupoint group"
                ], 
                "description": "Application containing herbal medicine that mainly include styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech and other herbal medicine.", 
                "intervention_name": "Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)", 
                "intervention_type": "Drug", 
                "other_name": "Herbal medicine application"
            }, 
            {
                "arm_group_label": [
                    "Herbal application on acupoint group", 
                    "Placebo application on acupoint"
                ], 
                "description": "select acupoint according to traditional Chinese medicine", 
                "intervention_name": "acupoint", 
                "intervention_type": "Device", 
                "other_name": "acupuncture point"
            }, 
            {
                "arm_group_label": [
                    "Herbal application on acupoint group", 
                    "Placebo application on acupoint", 
                    "Herbal application on non-acupoint group", 
                    "Placebo application on non-acupoint"
                ], 
                "description": "foundation treatment", 
                "intervention_name": "Aspirin: 100mg qd; Metoprolol\uff1a25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.", 
                "intervention_type": "Drug", 
                "other_name": "basic treatment"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Metoprolol", 
                "Atorvastatin"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Acupoint Application,Stable Angina Pectoris,herbal medicine", 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "contact": {
                "email": "1259362295@qq.com", 
                "last_name": "Dehua Li", 
                "phone": "18980079361"
            }, 
            "facility": {
                "address": {
                    "city": "Chengdu", 
                    "country": "China", 
                    "state": "Sichuan", 
                    "zip": "610072"
                }, 
                "name": "Affiliated hospital of Chengdu University of TCM"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Acupoint Application With Herbal Medicine in Patients With Stable Angina Pectoris: Randomized, Controlled,Double Blind Clinical Study", 
        "overall_contact": {
            "email": "912795954@qq.com", 
            "last_name": "Yulan Ren", 
            "phone": "13689098226"
        }, 
        "overall_official": {
            "affiliation": "Chengdu University of TCM", 
            "last_name": "Fanrong Liang", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "China: Science and Technology Department of Sichuan Province", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The change frequency of angina attack during every 4-week.", 
            "measure": "Change from Baseline  Number of angina attacks at 12 weeks", 
            "safety_issue": "Yes", 
            "time_frame": "at baseline,4, 8weeks after inclusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029118"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The VAS score evaluation angina pain severity", 
                "measure": "Change from Baseline  the severity of angina ( VAS score) at 12 weeks", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline,4, 8weeks after inclusion"
            }, 
            {
                "description": "Observed reduction in the dose of nitroglycerin", 
                "measure": "Change from Baseline the dosage of nitroglycerin at 12 weeks", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline,4, 8weeks after inclusion"
            }, 
            {
                "measure": "Seattle Angina Questionnaire", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline,4, 8weeks after inclusion"
            }, 
            {
                "measure": "self-rating anxiety scale", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline,4, 8weeks after inclusion"
            }, 
            {
                "measure": "Self-rating Depression Scale", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline,4, 8weeks after inclusion"
            }
        ], 
        "source": "Chengdu University of Traditional Chinese Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chengdu University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}